20/20 Biolabs stock surges on Ebola testing plans
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
20/20 Biolabs Inc (AIDX)
20/20 Biolabs Inc stock price live, this page displays NASDAQ AIDX stock exchange data. View the AIDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the 20/20 Biolabs Inc real time stock price chart below.
What Is the 20/20 Biolabs Inc Stock Price Today?
The 20/20 Biolabs Inc stock price today is 0.62.
What Is the Stock Symbol for 20/20 Biolabs Inc?
The stock symbol for 20/20 Biolabs Inc is "AIDX."
What Stock Exchange Does 20/20 Biolabs Inc Trade On?
20/20 Biolabs Inc is listed and trades on the NASDAQ stock exchange.
Is 20/20 Biolabs Inc a Good Stock to Buy?
Determining whether 20/20 Biolabs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AIDX quote. (ISIN: US90138K1016)
What Is the 20/20 Biolabs Inc Stock Price Today?
The 20/20 Biolabs Inc stock price today is 0.62.
What Is the Stock Symbol for 20/20 Biolabs Inc?
The stock symbol for 20/20 Biolabs Inc is "AIDX."
What Stock Exchange Does 20/20 Biolabs Inc Trade On?
20/20 Biolabs Inc is listed and trades on the NASDAQ stock exchange.
Is 20/20 Biolabs Inc a Good Stock to Buy?
Determining whether 20/20 Biolabs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AIDX quote. (ISIN: US90138K1016)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.59
0.65
52 wk Range
0.51
50.00
AIDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.590.65
52 wk Range
0.5150.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AIDX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
5.00
Upside
+706.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.00
(+706.45% Upside)
Earnings
Latest Release
May 20, 2026
EPS / Forecast
-0.28 / --
Revenue / Forecast
353.38K / --
Compare AIDX to Peers and Sector
Metrics to compare | AIDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAIDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −0.1x | −0.4x | |
PEG Ratio | −0.09 | 0.02 | 0.00 | |
Price/Book | 2.6x | 1.6x | 2.6x | |
Price / LTM Sales | 3.6x | 1.6x | 3.1x | |
Upside (Analyst Target) | - | 20.6% | 48.3% | |
Fair Value Upside | Unlock | 20.3% | 6.1% | Unlock |
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the 20/20 Biolabs (AIDX) Stock Price Today?
The 20/20 Biolabs stock price today is 0.62 USD.
What Stock Exchange Does 20/20 Biolabs Trade On?
20/20 Biolabs is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for 20/20 Biolabs?
The stock symbol for 20/20 Biolabs is "AIDX."
What Is the 20/20 Biolabs Market Cap?
As of today, 20/20 Biolabs market cap is 6.62M USD.
What Is 20/20 Biolabs's Earnings Per Share (TTM)?
The 20/20 Biolabs EPS (TTM) is -0.90.
When Is the Next 20/20 Biolabs Earnings Date?
20/20 Biolabs will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is AIDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has 20/20 Biolabs Stock Split?
20/20 Biolabs has split 0 times.
How Many Employees Does 20/20 Biolabs Have?
20/20 Biolabs has 9 employees.
What is the current trading status of 20/20 Biolabs (AIDX)?
As of Jul 07, 2026, 20/20 Biolabs (AIDX) is trading at a price of 0.62 USD, with a previous close of 0.62 USD. The stock has fluctuated within a day range of 0.59 USD to 0.65 USD, while its 52-week range spans from 0.51 USD to 50.00 USD.
What Is 20/20 Biolabs (AIDX) Price Target According to Analysts?
The average 12-month price target for 20/20 Biolabs is 5.00 USD, with a high estimate of 5 USD and a low estimate of 5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +706.45% Upside potential.
What Is the AIDX Premarket Price?
AIDX's last pre-market stock price is 0.60 USD. The pre-market share volume is 5,260.00, and the stock has decreased by -0.02, or -3.23%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.